| pubmed-article:17272747 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17272747 | lifeskim:mentions | umls-concept:C0026809 | lld:lifeskim |
| pubmed-article:17272747 | lifeskim:mentions | umls-concept:C0004153 | lld:lifeskim |
| pubmed-article:17272747 | lifeskim:mentions | umls-concept:C0001563 | lld:lifeskim |
| pubmed-article:17272747 | lifeskim:mentions | umls-concept:C0003591 | lld:lifeskim |
| pubmed-article:17272747 | lifeskim:mentions | umls-concept:C0449258 | lld:lifeskim |
| pubmed-article:17272747 | lifeskim:mentions | umls-concept:C0048897 | lld:lifeskim |
| pubmed-article:17272747 | lifeskim:mentions | umls-concept:C0439834 | lld:lifeskim |
| pubmed-article:17272747 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:17272747 | pubmed:dateCreated | 2007-3-22 | lld:pubmed |
| pubmed-article:17272747 | pubmed:abstractText | Although it has been reported that oral administration of tetrahydrobiopterin (BH4) prevents endothelial dysfunction and vascular oxidative stress in various rat models, the effect of treatment with BH4 on atherogenesis remains unclear. | lld:pubmed |
| pubmed-article:17272747 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17272747 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17272747 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17272747 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17272747 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17272747 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17272747 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17272747 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17272747 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17272747 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17272747 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:17272747 | pubmed:issn | 1524-4636 | lld:pubmed |
| pubmed-article:17272747 | pubmed:author | pubmed-author:HattoriYoshiy... | lld:pubmed |
| pubmed-article:17272747 | pubmed:author | pubmed-author:HattoriSachik... | lld:pubmed |
| pubmed-article:17272747 | pubmed:author | pubmed-author:KasaiKikuoK | lld:pubmed |
| pubmed-article:17272747 | pubmed:author | pubmed-author:NakanishiNobu... | lld:pubmed |
| pubmed-article:17272747 | pubmed:author | pubmed-author:WangXiX | lld:pubmed |
| pubmed-article:17272747 | pubmed:author | pubmed-author:SatohHirokoH | lld:pubmed |
| pubmed-article:17272747 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:17272747 | pubmed:volume | 27 | lld:pubmed |
| pubmed-article:17272747 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17272747 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17272747 | pubmed:pagination | 865-70 | lld:pubmed |
| pubmed-article:17272747 | pubmed:meshHeading | pubmed-meshheading:17272747... | lld:pubmed |
| pubmed-article:17272747 | pubmed:meshHeading | pubmed-meshheading:17272747... | lld:pubmed |
| pubmed-article:17272747 | pubmed:meshHeading | pubmed-meshheading:17272747... | lld:pubmed |
| pubmed-article:17272747 | pubmed:meshHeading | pubmed-meshheading:17272747... | lld:pubmed |
| pubmed-article:17272747 | pubmed:meshHeading | pubmed-meshheading:17272747... | lld:pubmed |
| pubmed-article:17272747 | pubmed:meshHeading | pubmed-meshheading:17272747... | lld:pubmed |
| pubmed-article:17272747 | pubmed:meshHeading | pubmed-meshheading:17272747... | lld:pubmed |
| pubmed-article:17272747 | pubmed:meshHeading | pubmed-meshheading:17272747... | lld:pubmed |
| pubmed-article:17272747 | pubmed:meshHeading | pubmed-meshheading:17272747... | lld:pubmed |
| pubmed-article:17272747 | pubmed:meshHeading | pubmed-meshheading:17272747... | lld:pubmed |
| pubmed-article:17272747 | pubmed:meshHeading | pubmed-meshheading:17272747... | lld:pubmed |
| pubmed-article:17272747 | pubmed:meshHeading | pubmed-meshheading:17272747... | lld:pubmed |
| pubmed-article:17272747 | pubmed:meshHeading | pubmed-meshheading:17272747... | lld:pubmed |
| pubmed-article:17272747 | pubmed:meshHeading | pubmed-meshheading:17272747... | lld:pubmed |
| pubmed-article:17272747 | pubmed:meshHeading | pubmed-meshheading:17272747... | lld:pubmed |
| pubmed-article:17272747 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17272747 | pubmed:articleTitle | Oral administration of tetrahydrobiopterin slows the progression of atherosclerosis in apolipoprotein E-knockout mice. | lld:pubmed |
| pubmed-article:17272747 | pubmed:affiliation | Department of Endocrinology & Metabolism, Dokkyo University School of Medicine, Mibu, Tochigi 321-0293, Japan. yhattori@dokkyomed.ac.jp | lld:pubmed |
| pubmed-article:17272747 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17272747 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17272747 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17272747 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17272747 | lld:pubmed |
